Interictal epileptiform discharges (IED) frequency is the most commonly studied interictal measure of ASM efficacy in patients with epilepsy, and IED suppression in a repeat pediatric EEG is usually interpreted as a reduced tendency towards seizures.
Objective
To assess whether the amplitude and morphology of IED can serve as surrogate measures of levetiracetam (LEV) efficacy in children with drug-resistant epilepsy.
Methods
Patients with refractory epilepsy, who were treated with oral LEV during a 5-year period, and who had at least 24 h long-term video-EEG recording (LTVEEG) before LEV was initiated and after attaining maximal dosage, were retrospectively selected from the database of the pediatric epilepsy clinic and LTVEEG monitoring unit. IED kurtosis (degree of peakedness), skewness (degree of asymmetry), and below-curve-area (area of the IED) were estimated by a signal processing analysis program.
Results
IED analysis in 20 patients aged 3.6 months to 15 years at maximal LEV dosage revealed increased kurtosis, increased skewness positivity and decreased below-curve-area compared to pre-treatment values. Visual analysis revealed a mean IED amplitude decrease in 30% of the patients, mainly in patients with generalized seizures. Neither the changes in IED measures nor the decrease of the visually determined IED amplitude correlated with decreased seizure frequency.
Conclusions
IED amplitude, kurtosis, skewness and below-curve-area were not correlated with seizure outcome after LEV initiation. Further studies with larger samples and additional seizure outcome measures are warranted.
AkmanCIMontenegeroMAJacobSEckKChiribogaCGilliamF. Seizure frequency in children with epilepsy: Factors influencing accuracy and parental awareness. Seizure. 2009;18(7):524-529.
2.
ModurPNRigdonB. Diagnostic yield of sequential routine EEG and extended outpatient video-EEG monitoring. Clin Neurophysiol. 2008;119(1):190-196.
3.
McGonigalARussellAJMallikAKOtoMDuncanR. Use of short term video EEG in the diagnosis of attack disorders. J Neurol Neurosurg Psychiatry. 2004;75(5):771-772.
4.
WorrellGALagerlundTDBuchhalterJR. Role and limitations of routine and ambulatory scalp electroencephalography in diagnosing and managing seizures. Mayo Clin Proc. 2002;77(9):991-998.
5.
PillaiJSperlingMR. Interictal EEG and the diagnosis of epilepsy. Epilepsia. 2006;47(Suppl 1):14-22.
6.
LibensonMHCaravaleB. Do antiepileptic drugs differ in suppressing interictal epileptiform activity in children?Pediatr Neurol. 2001;24(3):214-218.
7.
PlacidiFTombiniMRomigiA, et al.Topiramate: Effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy. Epilepsy Res. 2004;58(1):43-52.
8.
MarcianiMGSpaneddaFBassettiMA, et al.Effect of lamotrigine on EEG paroxysmal abnormalities and background activity: A computerized analysis. Br J Clin Oharmacol. 1996;42(5):621-627.
9.
StodieckSSteinhoffBJKolmseeSVan RijckevorselK. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges. Seizure. 2001;10(8):583-587.
10.
ZupancMLRoell WernerRSchwabeMS, et al.Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Pediatr Neurol. 2010;42(6):396-403.
11.
ErikssonASKnutssonENergårdhA. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy. Epilepsia. 2001;42(2):230-236.
12.
DuncanJSSmithSJForsterAShorvonSDTrimbleMR. Effects of the removal of phenytoin, carbamazepine, and valproate on the electroencephalogram. Epilepsia. 1989;30(5):590-596.
13.
DuncanJS. Antiepileptic drugs and the electroencephalogram. Epilepsia. 1987;28(3):259-266.
14.
BinnieCD. Cognitive impairment during epileptiform discharges: Is it ever justifiable to treat the EEG?Lancet Neurol. 2003;2(12):725-730.
15.
D'AntunonoMKöhlingRRIcalzoneSGotmanJBiaginiGAvoliM. Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro. Epilepsia. 2010;51(3):423-431.
16.
LarssonPGEeg-OlofssonOMichelCMSeeckMLantzG. Decrease in propagation of interictal epileptiform activity after introduction of levetiracetam visualized with electric source imaging. Brain Topogr. 2010;23(3):269-278.
17.
MattiaDSpaneddaFBassettiMA, et al.Gabapentin as add-on therapy in focal epilepsy: A computerized EEG study. Clin Neurophysiol. 2000;111(2):311-317.
18.
KimSHLimSCKimW, et al.Changes in background electroencephalography and regional cerebral glucose metabolism in focal epilepsy patients after 1-month administration of levetiracetam. Neuropsychiatr Dis Treat. 2015;11:215-223.
19.
LinLCOuyangCSChiangCTYangRCWuRCWuHC. Early prediction of medication refractoriness in children with idiopathic epilepsy based on scalp EEG analysis. Int J Neural Syst. 2014;24(7):1450023.
20.
HeymanELahatEGandelman-MartonR. Interictal encephalography can influence patient selection for methylprednisolone therapy in pediatric refractory epilepsy. J Child Neurol. 2012;27(2):162-167.
21.
AkiyamaTOsadaMIsowaM, et al.High kurtosis of intracranial electroencephalogram as a marker of ictogenicity in pediatric epilepsy surgery. Clin Neurophysiol. 2012;123(1):93-99.
22.
KlitgaardHMatagneAGrimeeRVanneste-GoemaereJMargineanuDG. Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy. Seizure. 2003;12(2):92-100.
23.
BergATBerkovicSFBrodieMJ, et al.Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia. 2010;51(4):676-685.
24.
DeCarloLT. On the meaning and use of kurtosis. Psychol Methods. 1997;2(3):292-307.
25.
Santiago-RodriguezEHarmonyTCardenas-MoralesLHernandezAFernandez-BouzasA. Analysis of background EEG activity in patients with juvenile myoclonic epilepsy. Seizure. 2008;17(5):437-445.
26.
LeeYJKangHCKimHDLeeJS. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy. Pediatr Neurol. 2010;42(2):86-92.
27.
GlauserTADulacO. Preliminary efficacy of levetiracetam in children. Epileptic Disord. 2003;5(Suppl 1):S45-S50.
28.
GloorP. The EEG and differential diagnosis of epilepsy. In: Van DuijnHDonkerDNJVan HuffelenAC, eds. Current concepts in clinical neurophysiology. Drukkerij Trio; 1977:9-21.
29.
LemieuxJFBlumeWT. Automated morphological analysis of spikes and sharp waves in human electrocorticograms. Electroencephal Clin Neurophysiol. 1983;55(1):45-50.
30.
GotmanJ. Quantitative measurements of epileptic spike morphology in the human EEG. Electroencephal Clin Neurophysiol. 1980;48(5):551-557.
31.
BlumeWTLemieuxJF. Morphology of spikes in spike-and-wave complexes. Electroencephal Clin Neurophysiol. 1988;69(6):508-515.
32.
FuetaYAvoliM. Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus. Epilepsy Res. 1992;12(3):207-215.
33.
BrücknerCHeinemannU. Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices. Brain Res. 2000;859(1):15-20.
34.
GlauserTAPellockJMBebinEM, et al.Efficacy and safety of levetiracetam in children with partial seizures: An open-label trial. Epilepsia. 2002;43(5):518-524.
35.
LagaeLBuyseGDeconinckACeulemansB. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Paed Neurol. 2003;7(3):123-128.
36.
TonekaboniSHGhazaviMKarimzadehPMahvelatiFGhofraniM. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial. Epilepsy Res. 2010;90(3):273-277.
37.
EgunsolaOChoonaraISammonsHM. Safety of levetiracetam in paediatrics: A systematic review. PLoS One. 2016;11(3):e0149686.
38.
HalmaEde LouwAJKlinkenbergSAldenkampAPIJffDMMajoieM. Behavioral side-effects of levetiracetam in children with epilepsy: A systematic review. Seizure. 2014;23(9):685-691.
